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abstract
PURPOSE Precision oncology depends on the matching of tumor variants to relevant knowledge describing the
clinical significance of those variants. We recently developed the Clinical Interpretations for Variants in Cancer
(CIViC; civicdb.org) crowd-sourced, expert-moderated, and open-access knowledgebase. CIViC provides
a structured framework for evaluating genomic variants of various types (eg, fusions, single-nucleotide variants)
for their therapeutic, prognostic, predisposing, diagnostic, or functional utility. CIViC has a documented ap-
plication programming interface for accessing CIViC records: assertions, evidence, variants, and genes. Third-
party tools that analyze or access the contents of this knowledgebase programmatically must leverage this
application programming interface, often reimplementing redundant functionality in the pursuit of common
analysis tasks that are beyond the scope of the CIViC Web application.
METHODS To address this limitation, we developed CIViCpy (civicpy.org), a software development kit for
extracting and analyzing the contents of the CIViC knowledgebase. CIViCpy enables users to query CIViC content
as dynamic objects in Python. We assess the viability of CIViCpy as a tool for advancing individualized patient
care by using it to systematically match CIViC evidence to observed variants in patient cancer samples.
RESULTSWe used CIViCpy to evaluate variants from 59,437 sequenced tumors of the American Association for
Cancer Research Project GENIE data set. We demonstrate that CIViCpy enables annotation of. 1,200 variants
per second, resulting in precise variant matches to CIViC level A (professional guideline) or B (clinical trial)
evidence for 38.6% of tumors.
CONCLUSION The clinical interpretation of genomic variants in cancers requires high-throughput tools for in-
teroperability and analysis of variant interpretation knowledge. These needs are met by CIViCpy, a software
development kit for downstream applications and rapid analysis. CIViCpy is fully documented, open-source, and
available free online.
JCO Clin Cancer Inform 4:245-253. © 2020 by American Society of Clinical Oncology
Licensed under the Creative Commons Attribution 4.0 License
INTRODUCTION
The use of massively parallel sequencing to profile the
molecular composition of human tissues has become
increasingly commonplace in the clinical setting to
inform diagnosis and therapeutic strategy for patients’
tumors.1,2 This has led to an ever-growing body of
biomedical literature describing the impact of tumor
variants on disease progression and response to
therapy, creating a bottleneck of expert review of
relevant literature to construct a clinical report.3 The
Clinical Interpretations for Variants in Cancer (CIViC)
community knowledgebase (civicdb.org) is a platform
for expert crowdsourcing the clinical interpretation of
variants in cancer.4 To date, CIViC contains 6,471
interpretation evidence records (ie, clinical signifi-
cance statements extracted from biomedical litera-
ture) describing 2,312 variants in 402 genes. Evidence
in CIViC is used to construct interpretation assertions of
clinical significance (ie, therapeutic, prognostic, di-
agnostic, or predisposing effects) of gene variants on
the basis of published criteria and guidelines for the
classification of variant interpretations.5,6 CIViC evi-
dence and assertions are also linked to data classes
describing genes, drugs (if applicable), and diseases,
in addition to the myriad supporting data for tracking
the provenance and community activity surrounding
these concepts and their relationships. These data are
released under a Creative Commons public domain
attribution (CC0), promoting their redistribution and
use in downstream applications.
As a curation platform for the Clinical Genome Re-
source (ClinGen) Somatic Working Group,7 CIViC
supports the export of generated assertions to ClinVar,
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germline diseases.8 This was accomplished through the
development of the civic2clinvar export utility and Python
package, which constructs ClinVar-style submission re-
cords from CIViC assertions.7 In developing civic2clinvar,
several issues with building an application from the CIViC
database and application programming interface (API)
were identified: (1) simplified retrieval and use of CIViC
records as native Python objects, (2) routines for local
caching of CIViC data for analysis, (3) support for high-
throughput queries, and (4) export of CIViC records to
established variant representation formats, such as variant
call format (VCF).9
Here, we describe CIViCpy, a software development kit
(SDK) that addresses these needs and enables rapid
downstream tool development and analysis by removing
the burden of implementing these features in independent
applications. We demonstrate the use of the SDK in an
associated analysis notebook to evaluate 59,437 tumors
from patients cataloged by the American Association for
Cancer Research Project GENIE cohort.10 CIViCpy is open-
source, Massachusetts Institute of Technology (MIT) li-
censed, and readily available for installation on the Python
Package Index (PyPI; pypi.org). CIViCpy documentation is
available online at civicpy.org.
METHODS
We designed the CIViCpy Python SDK as a standalone
package to retrieve the CIViC knowledgebase content and
transform responses into Python objects with intuitive
structures and interobject linkages. The resulting software
is a toolkit to support numerous downstream operations,
including exploratory analyses, variant annotation, and ap-
plication development (Fig 1). Here, we describe the opti-
mizations and design choices made to construct CIViCpy.
CIViCpy Objects
The primary data class in CIViCpy is the CivicRecord. This
class provides the framework for all first-class entities in
CIViC: Genes, Variants, Variant Groups, Evidence, and
Assertions. First-class entities are delineated from other
object classes in CIViC by the combination of persistent
public identifiers, dedicated API end points for returning
object details, and tracked provenance (Table 1). Prove-
nance tracking records the history of all actions taken on
the object as part of the CIViC curation cycle: object
submission, revisions, and editor approval. We also create
CivicRecord objects from CIViC Sources, Users, and Or-
ganizations, despite their lack of provenance tracking;
CivicRecord objects only require that a CIViC class is
identifiable and has supporting API end points. Docu-
mentation for each of the CivicRecord subclasses can be
found online at http://bit.ly/civicrecord-types.
The CIViCpy CivicAttribute is a data class for representing
composite data entities not captured by CivicRecord. This
includes composite entities with nested or list attributes (eg,
diseases, coordinates, or variant_aliases), as opposed to
primitive, single-valued entities (eg, description, allele_
registry_id, or evidence_direction). CivicAttribute inherits
from CivicRecord but is not indexed and accordingly
overrides many of the features of its parent class. Impor-
tantly, CivicAttribute is not cached (see Caching) except as
a linked object to other (non-CivicAttribute) CivicRecord
objects, and cannot be retrieved independently.
One of the strengths of the CivicRecord class is the ability
to dynamically evaluate nested CivicRecord objects. A
Variant, for instance, may have multiple associated Ev-
idence records, each of which may have a source linked
to multiple Evidence records describing other Variants.
A CivicRecord will automatically link nested objects;
consequently, one can chain through linked objects
when analyzing CIViC records to efficiently get to values
of interest, such as evaluating the Association for Mo-
lecular Pathology/ASCO/College of American Patholo-
gists somatic variant classification6 for a CIViC Assertion
(Fig 1, Object Inspection). Therefore, when evaluating evi-
dence for a variant using CIViCpy, the associated Evidence
CONTEXT
Key Objective
To develop a software development and analysis toolkit for performant search and inspection of records from the Clinical
Interpretations for Variants in Cancer (CIViC) knowledgebase.
Knowledge Generated
We developed the CIViCpy software development kit and analysis toolkit, a software package that enables high-throughput
retrieval and inspection of CIViC records. Useful features include precached content hosted live by CIViC, and utilities for
exporting CIViC content as variant call format (VCF) files.
Relevance
This work enables (1) building of downstream applications, such as the civic2clinvar ClinVar submission utility; (2) clinical analysis
tasks, such as the demonstrated analysis of the American Association for Cancer Research Project GENIE cohort; and (3) CIViC
integration into clinical annotation pipelines, via VCF export or direct record annotation with native Python objects.
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objects are returned rather than a list of evidence identifiers.
Evidence, in turn, will link to other CivicRecord objects (eg,
Assertion, Source), which can also be explored. An example of
exploring Assertions linked to a Variant using CIViCpy is
provided in the Data Supplement (see the CIViCpy Objects
section).
Querying CIViC
CIViC is built on a segregated server/client architecture,
where all functionality of the CIViC Web client is managed
through RESTful API calls to the underlying Rails server.
CIViCpy leverages this architectural design to post complex
queries to the CIViC advanced search API end points. This
enables high-throughput searches for records of interest,
including full data set requests. CIViC full data sets include
Evidence and Assertions in multiple states of the CIViC
review cycle: those that have been editor-reviewed and
approved (accepted), those that are pending review
(submitted), and those that have been rejected for inclusion
in CIViC. Because the CIViC full data set contains rejected
and submitted Evidence items and Assertions that have not
been approved by CIViC editors, these records may be
inaccurate, in a partial state, or incongruent with the CIViC
knowledge model.
CivicRecord objects may be retrieved by the corresponding
get_all functions (eg, get_all_variants(), get_all_assertions()).
These functions may optionally be passed a parameter for
explicitly including only objects of a given status. For ex-
ample, a user may request only evidence that has been
accepted or submitted (and exclude any rejected evi-
dence). Although these behaviors are readily reproducible
by users without leveraging this feature (eg, through in-
spection of evidence.status), we expect most downstream
workflows would desire to include only accepted and/or
submitted evidence, and so we have provided this func-
tionality as a convenience. An example of filtering evidence
by status using CIViCpy is provided in the Data Supplement
(see the Filtering Evidence section).
Caching
CIViCpy also is a standalone component for services
intended to perform large-volume operations on the CIViC
knowledgebase. A key design consideration, therefore, is





































>> from civicpy import civic





>> assertion.amp_level 'Tier I - Level A'
>> assertion.status
'accepted'
FIG 1. The CIViCpy software development kit (SDK). CIViCpy is a Python SDK and analysis toolkit for Clinical Interpretation of Variants in Cancer (CIViC). The
primary function of CIViCpy is to extract records from CIViC, convert them into linked Python objects, and provide useful tools and features for exploring and
analyzing those records. Caching: An important feature of CIViCpy is rapid retrieval via caching, with support for saving and loading CIViC record caches.
CIViCpy is used to build caches hosted on civicdb.org, which can be automatically downloaded to other CIViCpy clients for daily snapshots of all content in
CIViC. Object Inspection: CIViCpy enables dynamic evaluation of linked CIViC records through Python dot notation. Here, we see an example of the CIViCpy
library in use to explore details about an Association for Molecular Pathology Tier I somatic classification Assertion about ALK fusion transcripts. Python
Package: CIViCpy is available on the Python Package Index (PyPI), and is fully open source and permissively licensed for downstream applications. Formatted
Variant Export: CIViCpy supports the export of CIViC records into the established variant call format for use in annotation pipelines and existing bioinformatics
tools. App, application; MIT, Massachusetts Institute of Technology; VICC, Variant Interpretation for Cancer Consortium; VCF, variant call format.
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local indexing operations. When loaded, each cached
CivicRecord is assigned a unique key using the native
Python hash function, which is recomputed on loading
a stored cache from disk (by design, the hash seed
changes with each Python session). This hash is computed
on the CivicRecord type and id values, such that user-
generated partial CivicRecords with these minimal values
provide the same hash (and are treated as equivalent to)
complete CivicRecords.
Each cache also maintains a timestamp of when the cache
was last generated. This information is used when loading
the cache from file to determine whether a fresh cache
needs to be built or retrieved from a remote source. CIViCpy
will expire a cache 7 days (or after user-configurable length
of time) after it is initially built and will retrieve the newest
(nightly) cache from the CIViC live server. The local cache
can also be manually updated from the command line with
the civicpy update utility.
Variant Coordinate Search
When loading all variants from CIViC, a sorted variant co-
ordinate index is also constructed after cache generation to
enable coordinate search and lookup strategies (Fig 2A). A
similarly sorted list of CoordinateQuery objects represent
variants to query, such as those observed in a patient’s
tumor (Fig 2B). The index and CoordinateQuery objects are
used by the search algorithm for high-throughput searches
(Fig 2C). Importantly, the search algorithm supports the
notion of variant ranges for CIViC records and queries, and
provides several search modes to accommodate varying
sensitivity and specificity tradeoffs (Fig 2D).
Variant Exports
CIViCpy enables the export of CIViC Variant records and
their associated Evidence Items and Assertions into the VCF
(Fig 1) by providing a VCFWriter class. After instantiat-
ing a VCFWriter object, a Variant record may be added to
it for future output by calling the addrecord() function.
The addrecord() function supports various variant types,
depending on the curated coordinates available for a Var-
iant. All Variants require the chromosome name and start
position. For single-nucleotide variants and complex vari-
ants, the reference sequence and altered sequence in-
formation also must be available. By contrast, insertions
require only variant sequence information and deletions
require only reference sequence information. Variants that
do not meet theseminimum requirements will not be added
and a warning message is emitted instead. Fusions and
other variants with a second set of coordinates are currently
not supported. To verify whether a Variant can be added to
a VCFWriter object, the convenience method is_valid_for_
vcf() can be called on a Variant object before calling
addrecord(). More information about variant types that may
lack reference and variant sequence information (eg, fu-
sions) can be found at bit.ly/civic-coordinates. Those var-
iants that cannot be exported into the VCF format are still
retrievable as CIViCpy records. Once all desired variants are
added to the VCFWriter object, writerecords() needs to be
called to write the VCF file. An example of using CIViCpy to
generate a CIViC VCF file is provided in the Data Supple-
ment (see the Exporting to VCF section).
The variants added to the VCFWriter object are written to
the VCF file, one VCF record for each Variant object. If two
Variant objects share the same chromosome, start position,
and reference allele(s), they will not be combined into one
VCF record but instead will be written as separate VCF
records. Additional CIViC data are added to the VCF as
annotations to the CSQ (consequence) INFO field (Table 2).
CIViC Evidence items and Assertions linked to the Variant
TABLE 1. CIViC Class Entities
CIViC Object Provenance Tracking Persistent CIViC ID Detailed Record End Point CIViCpy Class
First-class entities
Genes Y Y Y CivicRecord
Variants Y Y Y CivicRecord
Variant groups Y Y Y CivicRecord
Evidence Y Y Y CivicRecord
Assertions Y Y Y CivicRecord
Second-class entities
User N Y Y CivicRecord
Organization N Y Y CivicRecord
Sources N N Y CivicRecord
Country N N N CivicAttribute
Drugs N N N CivicAttribute
Diseases N N N CivicAttribute
Phenotypes N N N CivicAttribute
Abbreviations: CIViC, Clinical Interpretations for Variants in Cancer; ID, identifier.
Wagner et al
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are added to the CSQ field with one CSQ entry for each
Evidence item and/or Assertion. Whether a specific CSQ
entry reflects an Evidence item or an Assertion is
determined by the CIViC Entity Type CSQ field. To differ-
entiate special characters in the field values from field
delimiters, spaces are replaced with underscores and
other special characters are hex encoded. By using the
CSQ field for annotations, the resulting VCF is compatible
for import into Google BigQuery (git.io/bigquery-variant-
annotation).
A command line utility, civicpy create-vcf, allows users
to create a VCF file of all supported CIViC variants. The
-i/– include-status required parameter will restrict the an-
notations to only those Evidence Items and Assertions that
Extract Coordinates
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FIG 2. Variant coordinate search with CIViCpy. (A) On updating or loading the in-memory cache, all variant records are extracted and converted into
a sorted Variant Coordinate Index (VCI). Variants missing coordinate values are excluded, and variants with compound coordinates (eg, fusion variants)
have the coordinates split into distinct records. Each coordinate is sorted by chromosome, start coordinate, stop coordinate, and alternate sequence (see
the purple box). The VCI also contains a reference to the cache key for the corresponding variant. The vci_ptr is a reference to a record of the VCI. (B)
CoordinateQuery objects are used to query against the VCI and should match the coordinate system requirements from CIViC (see the blue box). These
objects contain an optional key field for user reference. When searching the knowledgebase for several variants, CoordinateQuery objects should be
presorted by the same procedure for sorting the VCI. The q_ptr serves an analogous role to the vci_ptr for the variant queries. (C) Starting at the first sorted
VCI and Query record, searches will increment the smaller of the vci_ptr or q_ptr until an overlapping coordinate range is identified. When overlaps occur,
matches are reported on the basis of the searchmodel specified. The vci_ptr is restored once all overlapping records for a query are evaluated. (D) Several
searchmodels exist for this algorithm, including a highly sensitive Any search, a conservative Exact search, and two intermediatemodes. Overlap scenarios
and report behavior for each scenario are presented. 3, a scenario is reported; ✕, a scenario is not reported. QE, query encompassing; RE, record
encompassing.
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match the given status(es). If a variant does not have any
supporting Evidence Items or Assertions with the required
statuses, it will not be included in the VCF.
Software Engineering and Availability
The CIViCpy codebase is hosted publicly on GitHub (git.io/
civicpy). The test suite is implemented using the pytest
framework and GitHub integration tests are run using travis-
ci (travis-ci.org). Coveralls (https://coveralls.io/) is used to
track test coverage (77%). Code changes are integrated
using GitHub pull requests (https://github.com/griffithlab/
civicpy/pulls). Feature additions, user requests, and bug
reports are managed using GitHub issue tracking (https://
github.com/griffithlab/civicpy/issues). Collectively, these
features enable robust community development and fa-
cilitate adoption of the CIViCpy SDK.
User documentation is written using reStructuredText
markup language and the Sphinx documentation framework
(sphinx-doc.org). Documentation is hosted on Read the
Docs (readthedocs.org) and can be viewed at civicpy.org.
This documentation serves as both a “quick start” guide and
a detailed reference for developers and bioinformaticians.
This project is licensed under the MIT License (https://
opensource.org/licenses/MIT). CIViCpy has been packaged
and uploaded to the PyPI under the civicpy package name
and can be installed by running the pip install civicpy
command. Installation requires a Python version 3.7 en-
vironment. Releases are also made available on GitHub
(https://github.com/griffithlab/civicpy/releases).
GENIE Analysis
To evaluate the performance of CIViCpy in annotating patient
data, we performed a demonstrative analysis in a Jupyter
Notebook, available on the CIViCpy GitHub repository (git.io/
civicpy-genie). The Project GENIE10 version 5.0 extended
mutations file, which describes 445,655 variants across
59,437 patient tumors, was downloaded from https://www.
synapse.org/#!Synapse:syn17394041. Coordinates from the
reported variants were extracted and each coordinate set
was tagged using the corresponding tumor sample barcode.
TABLE 2. Variant Call Format CSQ Field Attributes
CSQ Field Description Compound Fielda
Allele Alternate allele N
Consequence CIViC sequence ontology variant types for this variant Y
SYMBOL HGNC gene symbol for the gene associated with this variant N
Entrez Gene ID Entrez gene ID for the gene associated with this variant N
Feature_type “transcript” N
Feature The Ensembl ID for the CIViC representative transcripts of this variant N
HGVSc Variant representation using HGVS notation (DNA level), corresponding to
the Feature
N
HGVSp Variant representation using HGVS notation (protein level), corresponding
to the Feature
N
CIViC Variant Name The CIViC variant name of this variant N
CIViC Variant ID The CIViC internal ID for this variant N
CIViC Variant Aliases CIViC aliases for this variant Y
CIViC HGVS CIViC HGVS strings for this variant Y
Allele Registry ID The allele registry ID for this variant N
ClinVar IDs ClinVar IDs associated with this variant Y
CIViC Variant Evidence Score The CIViC evidence score for this variant N
CIViC Entity Type The type of entity being annotated, either “evidence” or “assertion” N
CIViC Entity ID The CIViC internal ID for the entity being annotated N
CIViC Entity URL The CIViC direct URL to the entity being annotated N
CIViC Entity Source For evidence entities, the ID of the publication used to create the evidence
including the source type in the format “sourceId_(sourceType)”
N
CIViC Entity Variant Origin The variant origin of the entity being annotated, either “Somatic,” “Rare
Germline,” “Common Germline,” “Unknown,” or “N/A”
N
CIViC Entity Status The status of the CIViC entity being annotated, either “submitted,”
“accepted,” or “rejected”
N
Abbreviations: CIViC, Clinical interpretation of Variants in Cancer; CSQ, consequence; HGNC, HUGO Gene Nomenclature Committee; HGVS,
Human Genome Variation Society; ID, identifier; N/A, not applicable.
aCompound fields contain multiple values and use the ampersand (&) character to delineate values.
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The extracted coordinates were then transformed into
a sorted list of CIViCpy CoordinateQuery objects, which were
passed to the bulk-query search method using an exact
search strategy (Fig 2D). Match results and query times were
recorded for the full set of GENIE variants in addition to
timings from exponentially increasing subsets from one to
300,000. Match results from an anticonservative search
strategy, which allowed for any coordinate overlap (Fig 2D),
were also recorded.
Match results from the full set of variants were grouped by
tumor identifier and summarized by counts of Exact, Any,
and no matches. In addition, tumors for which no varia-
tions were reported for querying were also summarized.
Finally, we grouped tumors on the number of variants
matching CIViC evidence by Exact search, and summarized
the highest level of evidence found across the tumors in those
groups.
RESULTS
GENIE Tumor Variant Results
Using the Exact search strategy, CIViCpy successfully
matched CIViC evidence to 7.6% (n = 34,642) of GENIE
variants, and using the Any strategy, an additional 42.9%
of variants (n = 195,349) were matched (Fig 3A). Fur-
thermore, 46.3% of tumors (n = 27,545) had at least one
Exact match to a reported variant and an additional 40.2%
of tumors (n = 23,925) had at least one Any match.
Notably, 8.7% of tumors (n = 5,200) in the cohort had no
reported variants to query against the knowledgebase. We
evaluated the highest CIViC evidence level reported for the
27,545 tumors with matched evidence, and found 14.0%
of those tumors (n = 3,852) matched to a CIViC Validated
Association (Level A). An additional 69.3% of tumors (n =
19,098) matched to Clinical Evidence (Level B). Far fewer
tumors had Case Study (Level C, 11.8%; n= 3,248),
Preclinical (Level D, 3.9%; n = 1,066), or Inferential (Level
E, 1.0%; n = 281) as the highest-level evidence match
(Fig 3B). In total, 38.6% (n = 22,950) of all GENIE tumors
(including those without reported variants) had at least
one variant that matched to Level A or B evidence. Tumors
from the cohort had an average of 6.88 (median, 4) variants
reported, and although most tumors (53.7%; n = 31,892)
did not Exact match to CIViC variants, many tumors matched
one (35.4%; n = 21,026), two (9.4%; n = 5,592), three
(1.3%; n = 796), or more (0.2%; n = 131) CIViC variants.
A
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Variants Matched
Highest Evidence Level per Tumor
FIG 3. Variant coordinate search with CIViCpy. (A) Querying GENIE variants against the CIViC knowledgebase results in 7.6% (n = 34,642) of variant
(n = 445,655) and 46.3% (n = 27,545) of tumors (n = 59,437) with Exact matches to CIViC variants. Allowing for Any matches, these values increase to
50.5% of variants (n = 229,991) and 86.6% of tumors (n = 51,470). A small percentage (8.7%; n = 5,200) of all tumors had no reported variants with
which to search. (B) Tumors were grouped by the number of variants that Exact matched CIViC records. For each tumor, the highest level of evidence
supporting thematched variants was counted.We observed that 83.3%of tumors (n = 22,950) with Exact matching variants (which equates to 38.6%of all
tumors) were linked to CIViC Validated (Level A) or Clinical (Level B) evidence. (C) Response time of CIViCpy bulk queries against the CIViC knowl-
edgebase. As the number of variants queried increase . 1,000, response time is linear to the number of queries, with an increase in overall time of
0.808 ms/variant. CIViC, Clinical Interpretations for Variants in Cancer.
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CIViCpy Search Performance
CIViCpy uses a search strategy (Fig 2C) designed to scale
linearly with input query size. We evaluated the perfor-
mance of CIViCpy annotation of the GENIE cohort and
found that queries with ≥ 1,000 variants scale linearly with
input size, increasing total search time by approximately
0.808 ms/variant (Fig 3C). Queries with , 1,000 variants
exhibit higher performance and are returned in , 1 sec-
ond. We annotated the entire GENIE data set (n = 445,655
variants) in 369 seconds at a rate of 1,236 variants/s.
DISCUSSION
CIViCpy is an SDK and high-throughput analysis toolkit for
exploring and analyzing content within the CIViC knowl-
edgebase. CIViCpy has tools for object inspection, with
convenient features for record retrieval and search. Variant
annotation through CIViCpy is demonstrated to handle
variant searches at 1,236 variants/s through the provided
coordinate search methods. In addition, the SDK provides
convenient tools for exporting CIViC content to VCF for
integration in external annotation pipelines and tools.
The CIViCpy SDK has demonstrated utility in downstream
applications, including the previously published civic2clinvar
utility7 and the Variant Interpretation for Cancer Consortium.11
Additional features to improve CIViCpy are already being
planned, including extensions for other variant export formats
such as the Browser Extensible Data12 and the Global Alliance
for Genomics andHealth VR specification.13 These extensions
will also support export of variant types beyond the single-
nucleotide variants and insertions/deletions currently sup-
ported by our VCF export utility. In addition, we are planning
to develop utilities to allow users to annotate their own VCFs
with CIViC data. We are also developing strategies to in-
corporate CIViC Drug, Disease, and Phenotype entities as full
CivicRecord objects.
Finally, we have provided all source code for CIViCpy (git.io/
civicpy) and the analyses in this manuscript (git.io/cpy-
genie) in a public repository under the permissive MIT
license and have uploaded CIViCpy distributions to the PyPI
for ease of installation. The permissive licensing and easy
installation through PyPI allow for rapid integration into
existing analytical workflows. See our documentation and
project homepage at civicpy.org for more details.
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